Search clinical trials for: Stimulant Abuse

Total 8800 results

National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine-Cocaine Behavioral Intervention - 5

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence

Tobacco Dependence

United States
New York University

Completed

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Bupropion for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1

Schizophrenia | Tobacco Use Disorder | Tobacco Use Cessation
National Institute on Drug Abuse (NIDA)

Completed

Tyrosine for Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

Schizophrenia | Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic Features

United States
National Institute on Drug Abuse (NIDA)

Terminated

Nicotine Replacement Treatment for Pregnant Smokers - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Brain Changes in Stimulant Dependent Subjects - 8

Substance-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
GlaxoSmithKline

Completed

Smoking Treatment of Prisoners (STOP)

Tobacco Use Disorder | Tobacco Use Cessation

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3

Opioid-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Impact of Smoking Cessation on Sleep - 5

Tobacco Use Cessation | Sleep Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)

Withdrawn

Pemoline in the Treatment of Stimulant Dependence - 5

Cocaine-Related Disorders
National Institute on Drug Abuse (NIDA)

Completed

Modafinil for the Treatment of Cocaine Dependence - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Vigabatrin Ph 1 Cocaine Interaction Study

Cocaine Addiction

United States
National Institute on Drug Abuse (NIDA)
Friends Research Institute, Inc.

Completed

Methamphetamine Abuse Treatment in Patients With AIDS - 1

Substance-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Completed

Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2

Methamphetamine

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Completed

Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)

Methamphetamine Dependence | Methamphetamine Abuse

United States, Canada
National Institute on Drug Abuse (NIDA)
Friends Research Institute, Inc.

Completed

Flupenthixol Decanoate in Methamphetamine Smoking - 1

Substance-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1

Smoking Cessation | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)
Virginia Commonwealth University

Completed

Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke

Psychotic Disorders | Schizophrenia | Tobacco-Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Cognitive Correlates of Substance Abuse - 11

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Strategies to Help Adult ED Patients Quit Smoking

Tobacco Use

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Ph1 Lobeline Interaction Study - 1

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)

Unknown

Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1

Cocaine-Related Disorders | Drug Administration Schedule | Infusions, Intravenous

United States
National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Unknown

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)

Unknown

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Effects of Stimulant Dependence on Human Striatal Dopamine System - 15

Tobacco Use Disorder | Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1

Substance-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use (Brandswitch)

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Nicotine Lozenge to Reduce Smokeless Tobacco Use

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1

Smoking Cessation | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2

Smoking Cessation | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Reduction of Smoking in Cardiac Disease Patients

Cardiovascular Disease | Tobacco Use Disorder

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Monoamine Antagonist Therapies for Methamphetamine Abuse Prazosin (MATMA)

Continuous Methamphetamine Abuse

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Enhancing a High School Based Smoking Cessation Program

Nicotine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Pemoline for Cocaine Abuse - 7

Cocaine-Related Disorders

United States
University of Washington
National Institute on Drug Abuse (NIDA)

Completed

Stimulant Abuser Groups to Engage in 12-Step (STAGE-12)

Drug Abuse

United States
Massachusetts General Hospital
United States Department of Defense

Completed

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

ADHD | Stimulant-Induced Euphoria

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Four Models of Telephone Support for Stimulant Recovery

Drug Addiction

United States
University of Washington
National Institute on Drug Abuse (NIDA)

Completed

Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill

Schizophrenia | Bipolar Disorder | Major Depressive Disorder | Drug Abuse

United States

Search clinical trials for: Stimulant Abuse

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations